For severe symptomsparticularly signs of significant dehydration, persistent high fever, or bloody diarrhoeaattend your local Emergency Department or call 999 if symptoms are life-threatening
Results are from a 30-week, randomized, open-label, active-controlled trial in 1089 insulin-nave adult patients on metformin sulfonylurea with type 2 diabetes comparing Ozempic injection 0.5 mg and Ozempic injection 1 mg with Lantus
Semaglutide is a GLP-1 receptor agonist peptide used in research studying glucose metabolism, appetite regulation, and metabolic pathways
Semaglutide injection side effects like skin irritation can also occur at the injection site
As a GLP-1 receptor agonist, semaglutide binds to GLP-1 receptors distributed throughout the gastrointestinal tract, pancreas, and central nervous system